(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on ...

“We originally raised about six million from what we call friends and family, and then we also raised two and a ... it was ...

And when I evaluate every patient, I also evaluate their support network. Some women come with strong family support. Some women come alone. Some of those people need more handholding. I want to make ...

The Children’s Inn at the National Institutes of Health is breaking ground on a project that will allow the nonprofit to ...

There is a tidal wave of inheritance coming from an ageing Boomer generation to Millennials and Gen-Z which should be welcome ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

Diagnosed as a teenager, Stacey Kennedy-Conner has spent years navigating the unpredictable and often debilitating challenges ...

Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...